nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—ABCB1—lung cancer	0.155	1	CbGaD
Mifepristone—ABCC1—Paclitaxel—lung cancer	0.0333	0.0539	CbGbCtD
Mifepristone—ABCC1—Irinotecan—lung cancer	0.0329	0.0532	CbGbCtD
Mifepristone—ABCC1—Vinblastine—lung cancer	0.0292	0.0473	CbGbCtD
Mifepristone—ABCC1—Etoposide—lung cancer	0.0263	0.0426	CbGbCtD
Mifepristone—ABCC1—Docetaxel—lung cancer	0.0241	0.039	CbGbCtD
Mifepristone—CYP3A5—Gefitinib—lung cancer	0.0228	0.0369	CbGbCtD
Mifepristone—CYP3A5—Teniposide—lung cancer	0.0221	0.0358	CbGbCtD
Mifepristone—ABCC1—Doxorubicin—lung cancer	0.018	0.0291	CbGbCtD
Mifepristone—ABCC1—Methotrexate—lung cancer	0.0174	0.0281	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0165	0.0266	CbGbCtD
Mifepristone—CYP3A7—Paclitaxel—lung cancer	0.0165	0.0266	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0163	0.0263	CbGbCtD
Mifepristone—CYP3A7—Irinotecan—lung cancer	0.0163	0.0263	CbGbCtD
Mifepristone—ABCB1—Topotecan—lung cancer	0.0163	0.0263	CbGbCtD
Mifepristone—ABCB1—Gefitinib—lung cancer	0.0149	0.024	CbGbCtD
Mifepristone—CYP2D6—Gefitinib—lung cancer	0.014	0.0226	CbGbCtD
Mifepristone—CYP3A5—Crizotinib—lung cancer	0.014	0.0226	CbGbCtD
Mifepristone—CYP3A5—Erlotinib—lung cancer	0.0135	0.0218	CbGbCtD
Mifepristone—CYP3A5—Paclitaxel—lung cancer	0.0124	0.02	CbGbCtD
Mifepristone—CYP3A5—Irinotecan—lung cancer	0.0122	0.0197	CbGbCtD
Mifepristone—CYP3A7—Docetaxel—lung cancer	0.0119	0.0193	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.0119	0.0193	CbGbCtD
Mifepristone—ABCB1—Vinorelbine—lung cancer	0.0114	0.0185	CbGbCtD
Mifepristone—CYP2D6—Vinorelbine—lung cancer	0.0108	0.0174	CbGbCtD
Mifepristone—CYP3A5—Etoposide—lung cancer	0.00977	0.0158	CbGbCtD
Mifepristone—CYP3A4—Topotecan—lung cancer	0.00974	0.0157	CbGbCtD
Mifepristone—ABCB1—Crizotinib—lung cancer	0.00911	0.0147	CbGbCtD
Mifepristone—CYP3A5—Docetaxel—lung cancer	0.00894	0.0145	CbGbCtD
Mifepristone—CYP3A4—Gefitinib—lung cancer	0.00891	0.0144	CbGbCtD
Mifepristone—ABCB1—Gemcitabine—lung cancer	0.0089	0.0144	CbGbCtD
Mifepristone—ABCB1—Erlotinib—lung cancer	0.00879	0.0142	CbGbCtD
Mifepristone—CYP3A4—Teniposide—lung cancer	0.00864	0.014	CbGbCtD
Mifepristone—CYP2D6—Erlotinib—lung cancer	0.00828	0.0134	CbGbCtD
Mifepristone—ABCB1—Paclitaxel—lung cancer	0.00804	0.013	CbGbCtD
Mifepristone—ABCB1—Irinotecan—lung cancer	0.00794	0.0128	CbGbCtD
Mifepristone—ABCB1—Vinblastine—lung cancer	0.00706	0.0114	CbGbCtD
Mifepristone—CYP3A4—Vinorelbine—lung cancer	0.00686	0.0111	CbGbCtD
Mifepristone—CYP2D6—Vinblastine—lung cancer	0.00665	0.0108	CbGbCtD
Mifepristone—ABCB1—Cisplatin—lung cancer	0.00647	0.0105	CbGbCtD
Mifepristone—ABCB1—Etoposide—lung cancer	0.00636	0.0103	CbGbCtD
Mifepristone—ABCB1—Docetaxel—lung cancer	0.00582	0.0094	CbGbCtD
Mifepristone—CYP3A4—Crizotinib—lung cancer	0.00546	0.00883	CbGbCtD
Mifepristone—CYP3A4—Erlotinib—lung cancer	0.00527	0.00851	CbGbCtD
Mifepristone—CYP3A4—Paclitaxel—lung cancer	0.00482	0.00779	CbGbCtD
Mifepristone—CYP3A4—Irinotecan—lung cancer	0.00476	0.00769	CbGbCtD
Mifepristone—ABCB1—Doxorubicin—lung cancer	0.00434	0.00701	CbGbCtD
Mifepristone—CYP3A4—Vinblastine—lung cancer	0.00423	0.00684	CbGbCtD
Mifepristone—ABCB1—Methotrexate—lung cancer	0.0042	0.00679	CbGbCtD
Mifepristone—CYP2D6—Doxorubicin—lung cancer	0.00409	0.00661	CbGbCtD
Mifepristone—CYP3A4—Etoposide—lung cancer	0.00381	0.00616	CbGbCtD
Mifepristone—CYP3A4—Docetaxel—lung cancer	0.00348	0.00563	CbGbCtD
Mifepristone—CYP3A4—Doxorubicin—lung cancer	0.0026	0.0042	CbGbCtD
Mifepristone—PGR—mammary gland—lung cancer	0.000298	0.103	CbGeAlD
Mifepristone—PGR—respiratory system—lung cancer	0.000199	0.0687	CbGeAlD
Mifepristone—PGR—epithelium—lung cancer	0.000166	0.0574	CbGeAlD
Mifepristone—Anxiety—Paclitaxel—lung cancer	0.000145	0.00105	CcSEcCtD
Mifepristone—Malnutrition—Docetaxel—lung cancer	0.000145	0.00105	CcSEcCtD
Mifepristone—Decreased appetite—Gemcitabine—lung cancer	0.000145	0.00105	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000144	0.00105	CcSEcCtD
Mifepristone—Nausea—Topotecan—lung cancer	0.000144	0.00104	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000144	0.00104	CcSEcCtD
Mifepristone—Discomfort—Paclitaxel—lung cancer	0.000143	0.00104	CcSEcCtD
Mifepristone—Fatigue—Gemcitabine—lung cancer	0.000143	0.00104	CcSEcCtD
Mifepristone—Pain—Gemcitabine—lung cancer	0.000142	0.00103	CcSEcCtD
Mifepristone—Constipation—Gemcitabine—lung cancer	0.000142	0.00103	CcSEcCtD
Mifepristone—Nausea—Erlotinib—lung cancer	0.000142	0.00103	CcSEcCtD
Mifepristone—Dry mouth—Paclitaxel—lung cancer	0.000142	0.00103	CcSEcCtD
Mifepristone—Diarrhoea—Vinorelbine—lung cancer	0.000142	0.00103	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000141	0.00102	CcSEcCtD
Mifepristone—Infection—Etoposide—lung cancer	0.000141	0.00102	CcSEcCtD
Mifepristone—Feeling abnormal—Irinotecan—lung cancer	0.000141	0.00102	CcSEcCtD
Mifepristone—Back pain—Docetaxel—lung cancer	0.00014	0.00101	CcSEcCtD
Mifepristone—Gastrointestinal pain—Irinotecan—lung cancer	0.00014	0.00101	CcSEcCtD
Mifepristone—Oedema—Paclitaxel—lung cancer	0.000139	0.00101	CcSEcCtD
Mifepristone—Muscle spasms—Docetaxel—lung cancer	0.000139	0.00101	CcSEcCtD
Mifepristone—Infection—Paclitaxel—lung cancer	0.000138	0.001	CcSEcCtD
Mifepristone—Dyspnoea—Cisplatin—lung cancer	0.000138	0.001	CcSEcCtD
Mifepristone—Skin disorder—Etoposide—lung cancer	0.000138	0.001	CcSEcCtD
Mifepristone—Feeling abnormal—Gemcitabine—lung cancer	0.000137	0.000993	CcSEcCtD
Mifepristone—Dizziness—Vinorelbine—lung cancer	0.000137	0.000992	CcSEcCtD
Mifepristone—Nervous system disorder—Paclitaxel—lung cancer	0.000137	0.00099	CcSEcCtD
Mifepristone—Hypokalaemia—Doxorubicin—lung cancer	0.000136	0.000988	CcSEcCtD
Mifepristone—Breast disorder—Doxorubicin—lung cancer	0.000135	0.000981	CcSEcCtD
Mifepristone—Anorexia—Etoposide—lung cancer	0.000135	0.000981	CcSEcCtD
Mifepristone—Skin disorder—Paclitaxel—lung cancer	0.000135	0.00098	CcSEcCtD
Mifepristone—Abdominal pain—Irinotecan—lung cancer	0.000135	0.000978	CcSEcCtD
Mifepristone—Body temperature increased—Irinotecan—lung cancer	0.000135	0.000978	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000135	0.000978	CcSEcCtD
Mifepristone—Decreased appetite—Cisplatin—lung cancer	0.000135	0.000977	CcSEcCtD
Mifepristone—Nasopharyngitis—Doxorubicin—lung cancer	0.000134	0.000971	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Cisplatin—lung cancer	0.000134	0.00097	CcSEcCtD
Mifepristone—Infestation—Methotrexate—lung cancer	0.000133	0.000967	CcSEcCtD
Mifepristone—Infestation NOS—Methotrexate—lung cancer	0.000133	0.000967	CcSEcCtD
Mifepristone—Anorexia—Paclitaxel—lung cancer	0.000133	0.000962	CcSEcCtD
Mifepristone—Hypotension—Etoposide—lung cancer	0.000133	0.000962	CcSEcCtD
Mifepristone—Pain—Cisplatin—lung cancer	0.000133	0.000961	CcSEcCtD
Mifepristone—AR—epithelium—lung cancer	0.000132	0.0457	CbGeAlD
Mifepristone—Muscular weakness—Doxorubicin—lung cancer	0.000132	0.000958	CcSEcCtD
Mifepristone—Vomiting—Vinorelbine—lung cancer	0.000132	0.000954	CcSEcCtD
Mifepristone—Body temperature increased—Gemcitabine—lung cancer	0.000131	0.000953	CcSEcCtD
Mifepristone—Rash—Vinorelbine—lung cancer	0.00013	0.000946	CcSEcCtD
Mifepristone—Dermatitis—Vinorelbine—lung cancer	0.00013	0.000945	CcSEcCtD
Mifepristone—AR—bronchus—lung cancer	0.00013	0.045	CbGeAlD
Mifepristone—Hypotension—Paclitaxel—lung cancer	0.00013	0.000943	CcSEcCtD
Mifepristone—Headache—Vinorelbine—lung cancer	0.00013	0.00094	CcSEcCtD
Mifepristone—Feeling abnormal—Cisplatin—lung cancer	0.000128	0.000926	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000127	0.000919	CcSEcCtD
Mifepristone—Dyspnoea—Etoposide—lung cancer	0.000127	0.000918	CcSEcCtD
Mifepristone—Somnolence—Etoposide—lung cancer	0.000126	0.000915	CcSEcCtD
Mifepristone—Insomnia—Paclitaxel—lung cancer	0.000126	0.000913	CcSEcCtD
Mifepristone—Hypersensitivity—Irinotecan—lung cancer	0.000126	0.000912	CcSEcCtD
Mifepristone—Hypertension—Docetaxel—lung cancer	0.000125	0.000905	CcSEcCtD
Mifepristone—Dyspnoea—Paclitaxel—lung cancer	0.000124	0.0009	CcSEcCtD
Mifepristone—Somnolence—Paclitaxel—lung cancer	0.000124	0.000897	CcSEcCtD
Mifepristone—ABCC1—bronchus—lung cancer	0.000124	0.0428	CbGeAlD
Mifepristone—Decreased appetite—Etoposide—lung cancer	0.000123	0.000895	CcSEcCtD
Mifepristone—Arthralgia—Docetaxel—lung cancer	0.000123	0.000892	CcSEcCtD
Mifepristone—Myalgia—Docetaxel—lung cancer	0.000123	0.000892	CcSEcCtD
Mifepristone—Nausea—Vinorelbine—lung cancer	0.000123	0.000891	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Etoposide—lung cancer	0.000123	0.000889	CcSEcCtD
Mifepristone—Body temperature increased—Cisplatin—lung cancer	0.000123	0.000888	CcSEcCtD
Mifepristone—Asthenia—Irinotecan—lung cancer	0.000122	0.000888	CcSEcCtD
Mifepristone—Fatigue—Etoposide—lung cancer	0.000122	0.000887	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000122	0.000886	CcSEcCtD
Mifepristone—Pain—Etoposide—lung cancer	0.000121	0.00088	CcSEcCtD
Mifepristone—Constipation—Etoposide—lung cancer	0.000121	0.00088	CcSEcCtD
Mifepristone—Decreased appetite—Paclitaxel—lung cancer	0.000121	0.000877	CcSEcCtD
Mifepristone—Dry mouth—Docetaxel—lung cancer	0.00012	0.000873	CcSEcCtD
Mifepristone—Haemoglobin—Methotrexate—lung cancer	0.00012	0.000872	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00012	0.000871	CcSEcCtD
Mifepristone—Fatigue—Paclitaxel—lung cancer	0.00012	0.00087	CcSEcCtD
Mifepristone—Haemorrhage—Methotrexate—lung cancer	0.00012	0.000868	CcSEcCtD
Mifepristone—Asthenia—Gemcitabine—lung cancer	0.000119	0.000865	CcSEcCtD
Mifepristone—Constipation—Paclitaxel—lung cancer	0.000119	0.000863	CcSEcCtD
Mifepristone—Pain—Paclitaxel—lung cancer	0.000119	0.000863	CcSEcCtD
Mifepristone—Oedema—Docetaxel—lung cancer	0.000118	0.000855	CcSEcCtD
Mifepristone—Pruritus—Gemcitabine—lung cancer	0.000118	0.000853	CcSEcCtD
Mifepristone—Infection—Docetaxel—lung cancer	0.000117	0.00085	CcSEcCtD
Mifepristone—Feeling abnormal—Etoposide—lung cancer	0.000117	0.000848	CcSEcCtD
Mifepristone—Diarrhoea—Irinotecan—lung cancer	0.000117	0.000847	CcSEcCtD
Mifepristone—Gastrointestinal pain—Etoposide—lung cancer	0.000116	0.000842	CcSEcCtD
Mifepristone—Nervous system disorder—Docetaxel—lung cancer	0.000116	0.000839	CcSEcCtD
Mifepristone—CYP3A5—respiratory system—lung cancer	0.000115	0.0399	CbGeAlD
Mifepristone—Infestation—Doxorubicin—lung cancer	0.000115	0.000837	CcSEcCtD
Mifepristone—Infestation NOS—Doxorubicin—lung cancer	0.000115	0.000837	CcSEcCtD
Mifepristone—Feeling abnormal—Paclitaxel—lung cancer	0.000115	0.000832	CcSEcCtD
Mifepristone—Skin disorder—Docetaxel—lung cancer	0.000115	0.000831	CcSEcCtD
Mifepristone—NR3C1—respiratory system—lung cancer	0.000115	0.0396	CbGeAlD
Mifepristone—Hypersensitivity—Cisplatin—lung cancer	0.000114	0.000828	CcSEcCtD
Mifepristone—Gastrointestinal pain—Paclitaxel—lung cancer	0.000114	0.000825	CcSEcCtD
Mifepristone—Diarrhoea—Gemcitabine—lung cancer	0.000114	0.000825	CcSEcCtD
Mifepristone—Dizziness—Irinotecan—lung cancer	0.000113	0.000818	CcSEcCtD
Mifepristone—Urticaria—Etoposide—lung cancer	0.000113	0.000818	CcSEcCtD
Mifepristone—Anorexia—Docetaxel—lung cancer	0.000112	0.000815	CcSEcCtD
Mifepristone—Body temperature increased—Etoposide—lung cancer	0.000112	0.000814	CcSEcCtD
Mifepristone—Abdominal pain—Etoposide—lung cancer	0.000112	0.000814	CcSEcCtD
Mifepristone—Asthenia—Cisplatin—lung cancer	0.000111	0.000806	CcSEcCtD
Mifepristone—ABCC1—trachea—lung cancer	0.000111	0.0384	CbGeAlD
Mifepristone—Urticaria—Paclitaxel—lung cancer	0.000111	0.000802	CcSEcCtD
Mifepristone—Hypotension—Docetaxel—lung cancer	0.00011	0.000799	CcSEcCtD
Mifepristone—Body temperature increased—Paclitaxel—lung cancer	0.00011	0.000798	CcSEcCtD
Mifepristone—Abdominal pain—Paclitaxel—lung cancer	0.00011	0.000798	CcSEcCtD
Mifepristone—AR—cardiac atrium—lung cancer	0.00011	0.038	CbGeAlD
Mifepristone—Angiopathy—Methotrexate—lung cancer	0.000109	0.000787	CcSEcCtD
Mifepristone—Vomiting—Irinotecan—lung cancer	0.000109	0.000787	CcSEcCtD
Mifepristone—Sinusitis—Doxorubicin—lung cancer	0.000108	0.000785	CcSEcCtD
Mifepristone—Mediastinal disorder—Methotrexate—lung cancer	0.000108	0.000782	CcSEcCtD
Mifepristone—Rash—Irinotecan—lung cancer	0.000108	0.00078	CcSEcCtD
Mifepristone—Dermatitis—Irinotecan—lung cancer	0.000108	0.000779	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000107	0.000779	CcSEcCtD
Mifepristone—Chills—Methotrexate—lung cancer	0.000107	0.000779	CcSEcCtD
Mifepristone—Headache—Irinotecan—lung cancer	0.000107	0.000775	CcSEcCtD
Mifepristone—Insomnia—Docetaxel—lung cancer	0.000107	0.000774	CcSEcCtD
Mifepristone—Diarrhoea—Cisplatin—lung cancer	0.000106	0.000769	CcSEcCtD
Mifepristone—Vomiting—Gemcitabine—lung cancer	0.000106	0.000766	CcSEcCtD
Mifepristone—PGR—lung—lung cancer	0.000105	0.0365	CbGeAlD
Mifepristone—Dyspnoea—Docetaxel—lung cancer	0.000105	0.000763	CcSEcCtD
Mifepristone—Somnolence—Docetaxel—lung cancer	0.000105	0.00076	CcSEcCtD
Mifepristone—Mental disorder—Methotrexate—lung cancer	0.000105	0.00076	CcSEcCtD
Mifepristone—Rash—Gemcitabine—lung cancer	0.000105	0.00076	CcSEcCtD
Mifepristone—Dermatitis—Gemcitabine—lung cancer	0.000105	0.000759	CcSEcCtD
Mifepristone—Hypersensitivity—Etoposide—lung cancer	0.000105	0.000758	CcSEcCtD
Mifepristone—ABCC1—cardiac atrium—lung cancer	0.000104	0.0361	CbGeAlD
Mifepristone—Malnutrition—Methotrexate—lung cancer	0.000104	0.000755	CcSEcCtD
Mifepristone—Haemoglobin—Doxorubicin—lung cancer	0.000104	0.000755	CcSEcCtD
Mifepristone—Headache—Gemcitabine—lung cancer	0.000104	0.000755	CcSEcCtD
Mifepristone—Haemorrhage—Doxorubicin—lung cancer	0.000104	0.000751	CcSEcCtD
Mifepristone—Decreased appetite—Docetaxel—lung cancer	0.000103	0.000744	CcSEcCtD
Mifepristone—Hypersensitivity—Paclitaxel—lung cancer	0.000103	0.000744	CcSEcCtD
Mifepristone—Oedema peripheral—Doxorubicin—lung cancer	0.000102	0.00074	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Docetaxel—lung cancer	0.000102	0.000738	CcSEcCtD
Mifepristone—Asthenia—Etoposide—lung cancer	0.000102	0.000738	CcSEcCtD
Mifepristone—Connective tissue disorder—Doxorubicin—lung cancer	0.000102	0.000738	CcSEcCtD
Mifepristone—Fatigue—Docetaxel—lung cancer	0.000102	0.000737	CcSEcCtD
Mifepristone—Nausea—Irinotecan—lung cancer	0.000101	0.000735	CcSEcCtD
Mifepristone—Constipation—Docetaxel—lung cancer	0.000101	0.000731	CcSEcCtD
Mifepristone—Pain—Docetaxel—lung cancer	0.000101	0.000731	CcSEcCtD
Mifepristone—Back pain—Methotrexate—lung cancer	0.000101	0.000731	CcSEcCtD
Mifepristone—Pruritus—Etoposide—lung cancer	0.0001	0.000728	CcSEcCtD
Mifepristone—Asthenia—Paclitaxel—lung cancer	9.99e-05	0.000724	CcSEcCtD
Mifepristone—Nausea—Gemcitabine—lung cancer	9.88e-05	0.000716	CcSEcCtD
Mifepristone—Vomiting—Cisplatin—lung cancer	9.85e-05	0.000714	CcSEcCtD
Mifepristone—Pruritus—Paclitaxel—lung cancer	9.85e-05	0.000714	CcSEcCtD
Mifepristone—Rash—Cisplatin—lung cancer	9.77e-05	0.000708	CcSEcCtD
Mifepristone—Dermatitis—Cisplatin—lung cancer	9.76e-05	0.000708	CcSEcCtD
Mifepristone—Feeling abnormal—Docetaxel—lung cancer	9.72e-05	0.000705	CcSEcCtD
Mifepristone—Diarrhoea—Etoposide—lung cancer	9.71e-05	0.000704	CcSEcCtD
Mifepristone—Ill-defined disorder—Methotrexate—lung cancer	9.67e-05	0.000701	CcSEcCtD
Mifepristone—Gastrointestinal pain—Docetaxel—lung cancer	9.65e-05	0.000699	CcSEcCtD
Mifepristone—NR3C1—epithelium—lung cancer	9.58e-05	0.0331	CbGeAlD
Mifepristone—Diarrhoea—Paclitaxel—lung cancer	9.52e-05	0.00069	CcSEcCtD
Mifepristone—NR3C1—bronchus—lung cancer	9.43e-05	0.0326	CbGeAlD
Mifepristone—Angiopathy—Doxorubicin—lung cancer	9.4e-05	0.000682	CcSEcCtD
Mifepristone—Malaise—Methotrexate—lung cancer	9.4e-05	0.000681	CcSEcCtD
Mifepristone—Dizziness—Etoposide—lung cancer	9.39e-05	0.000681	CcSEcCtD
Mifepristone—Mediastinal disorder—Doxorubicin—lung cancer	9.34e-05	0.000677	CcSEcCtD
Mifepristone—Abdominal pain—Docetaxel—lung cancer	9.33e-05	0.000676	CcSEcCtD
Mifepristone—Body temperature increased—Docetaxel—lung cancer	9.33e-05	0.000676	CcSEcCtD
Mifepristone—Chills—Doxorubicin—lung cancer	9.3e-05	0.000674	CcSEcCtD
Mifepristone—Dizziness—Paclitaxel—lung cancer	9.21e-05	0.000667	CcSEcCtD
Mifepristone—Nausea—Cisplatin—lung cancer	9.21e-05	0.000667	CcSEcCtD
Mifepristone—Mental disorder—Doxorubicin—lung cancer	9.08e-05	0.000658	CcSEcCtD
Mifepristone—Vomiting—Etoposide—lung cancer	9.03e-05	0.000654	CcSEcCtD
Mifepristone—Malnutrition—Doxorubicin—lung cancer	9.02e-05	0.000654	CcSEcCtD
Mifepristone—Rash—Etoposide—lung cancer	8.95e-05	0.000649	CcSEcCtD
Mifepristone—Dermatitis—Etoposide—lung cancer	8.94e-05	0.000648	CcSEcCtD
Mifepristone—Headache—Etoposide—lung cancer	8.89e-05	0.000645	CcSEcCtD
Mifepristone—Myalgia—Methotrexate—lung cancer	8.87e-05	0.000643	CcSEcCtD
Mifepristone—Arthralgia—Methotrexate—lung cancer	8.87e-05	0.000643	CcSEcCtD
Mifepristone—Vomiting—Paclitaxel—lung cancer	8.85e-05	0.000642	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	8.81e-05	0.000639	CcSEcCtD
Mifepristone—Rash—Paclitaxel—lung cancer	8.78e-05	0.000636	CcSEcCtD
Mifepristone—Dermatitis—Paclitaxel—lung cancer	8.77e-05	0.000636	CcSEcCtD
Mifepristone—Discomfort—Methotrexate—lung cancer	8.76e-05	0.000635	CcSEcCtD
Mifepristone—Back pain—Doxorubicin—lung cancer	8.73e-05	0.000633	CcSEcCtD
Mifepristone—Headache—Paclitaxel—lung cancer	8.72e-05	0.000632	CcSEcCtD
Mifepristone—Hypersensitivity—Docetaxel—lung cancer	8.69e-05	0.00063	CcSEcCtD
Mifepristone—Muscle spasms—Doxorubicin—lung cancer	8.67e-05	0.000629	CcSEcCtD
Mifepristone—NR3C1—trachea—lung cancer	8.47e-05	0.0293	CbGeAlD
Mifepristone—Asthenia—Docetaxel—lung cancer	8.47e-05	0.000614	CcSEcCtD
Mifepristone—Infection—Methotrexate—lung cancer	8.45e-05	0.000612	CcSEcCtD
Mifepristone—Nausea—Etoposide—lung cancer	8.43e-05	0.000611	CcSEcCtD
Mifepristone—AR—lung—lung cancer	8.4e-05	0.0291	CbGeAlD
Mifepristone—Ill-defined disorder—Doxorubicin—lung cancer	8.37e-05	0.000607	CcSEcCtD
Mifepristone—Pruritus—Docetaxel—lung cancer	8.35e-05	0.000605	CcSEcCtD
Mifepristone—Nervous system disorder—Methotrexate—lung cancer	8.34e-05	0.000605	CcSEcCtD
Mifepristone—Nausea—Paclitaxel—lung cancer	8.27e-05	0.000599	CcSEcCtD
Mifepristone—Skin disorder—Methotrexate—lung cancer	8.26e-05	0.000599	CcSEcCtD
Mifepristone—Malaise—Doxorubicin—lung cancer	8.14e-05	0.00059	CcSEcCtD
Mifepristone—Anorexia—Methotrexate—lung cancer	8.11e-05	0.000588	CcSEcCtD
Mifepristone—Diarrhoea—Docetaxel—lung cancer	8.07e-05	0.000585	CcSEcCtD
Mifepristone—ABCC1—lung—lung cancer	7.98e-05	0.0276	CbGeAlD
Mifepristone—NR3C1—cardiac atrium—lung cancer	7.95e-05	0.0275	CbGeAlD
Mifepristone—Hypotension—Methotrexate—lung cancer	7.95e-05	0.000576	CcSEcCtD
Mifepristone—Dizziness—Docetaxel—lung cancer	7.8e-05	0.000566	CcSEcCtD
Mifepristone—Hypertension—Doxorubicin—lung cancer	7.79e-05	0.000565	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Methotrexate—lung cancer	7.75e-05	0.000562	CcSEcCtD
Mifepristone—Insomnia—Methotrexate—lung cancer	7.69e-05	0.000558	CcSEcCtD
Mifepristone—Arthralgia—Doxorubicin—lung cancer	7.68e-05	0.000557	CcSEcCtD
Mifepristone—Myalgia—Doxorubicin—lung cancer	7.68e-05	0.000557	CcSEcCtD
Mifepristone—Anxiety—Doxorubicin—lung cancer	7.65e-05	0.000555	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	7.63e-05	0.000553	CcSEcCtD
Mifepristone—Discomfort—Doxorubicin—lung cancer	7.59e-05	0.00055	CcSEcCtD
Mifepristone—Dyspnoea—Methotrexate—lung cancer	7.58e-05	0.00055	CcSEcCtD
Mifepristone—Somnolence—Methotrexate—lung cancer	7.56e-05	0.000548	CcSEcCtD
Mifepristone—Dry mouth—Doxorubicin—lung cancer	7.51e-05	0.000545	CcSEcCtD
Mifepristone—Vomiting—Docetaxel—lung cancer	7.5e-05	0.000544	CcSEcCtD
Mifepristone—Rash—Docetaxel—lung cancer	7.44e-05	0.000539	CcSEcCtD
Mifepristone—Dermatitis—Docetaxel—lung cancer	7.43e-05	0.000539	CcSEcCtD
Mifepristone—Decreased appetite—Methotrexate—lung cancer	7.39e-05	0.000536	CcSEcCtD
Mifepristone—Headache—Docetaxel—lung cancer	7.39e-05	0.000536	CcSEcCtD
Mifepristone—Oedema—Doxorubicin—lung cancer	7.36e-05	0.000534	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Methotrexate—lung cancer	7.34e-05	0.000532	CcSEcCtD
Mifepristone—Fatigue—Methotrexate—lung cancer	7.33e-05	0.000532	CcSEcCtD
Mifepristone—Infection—Doxorubicin—lung cancer	7.32e-05	0.00053	CcSEcCtD
Mifepristone—Pain—Methotrexate—lung cancer	7.27e-05	0.000527	CcSEcCtD
Mifepristone—Nervous system disorder—Doxorubicin—lung cancer	7.22e-05	0.000524	CcSEcCtD
Mifepristone—PGR—lymph node—lung cancer	7.21e-05	0.0249	CbGeAlD
Mifepristone—Skin disorder—Doxorubicin—lung cancer	7.15e-05	0.000519	CcSEcCtD
Mifepristone—Anorexia—Doxorubicin—lung cancer	7.02e-05	0.000509	CcSEcCtD
Mifepristone—Nausea—Docetaxel—lung cancer	7.01e-05	0.000508	CcSEcCtD
Mifepristone—Feeling abnormal—Methotrexate—lung cancer	7.01e-05	0.000508	CcSEcCtD
Mifepristone—Gastrointestinal pain—Methotrexate—lung cancer	6.95e-05	0.000504	CcSEcCtD
Mifepristone—Hypotension—Doxorubicin—lung cancer	6.88e-05	0.000499	CcSEcCtD
Mifepristone—Urticaria—Methotrexate—lung cancer	6.76e-05	0.00049	CcSEcCtD
Mifepristone—Abdominal pain—Methotrexate—lung cancer	6.72e-05	0.000487	CcSEcCtD
Mifepristone—Body temperature increased—Methotrexate—lung cancer	6.72e-05	0.000487	CcSEcCtD
Mifepristone—NR3C1—bone marrow—lung cancer	6.72e-05	0.0232	CbGeAlD
Mifepristone—Musculoskeletal discomfort—Doxorubicin—lung cancer	6.71e-05	0.000486	CcSEcCtD
Mifepristone—Insomnia—Doxorubicin—lung cancer	6.66e-05	0.000483	CcSEcCtD
Mifepristone—Dyspnoea—Doxorubicin—lung cancer	6.57e-05	0.000476	CcSEcCtD
Mifepristone—Somnolence—Doxorubicin—lung cancer	6.55e-05	0.000475	CcSEcCtD
Mifepristone—Decreased appetite—Doxorubicin—lung cancer	6.4e-05	0.000464	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Doxorubicin—lung cancer	6.36e-05	0.000461	CcSEcCtD
Mifepristone—Fatigue—Doxorubicin—lung cancer	6.35e-05	0.00046	CcSEcCtD
Mifepristone—Pain—Doxorubicin—lung cancer	6.3e-05	0.000456	CcSEcCtD
Mifepristone—Constipation—Doxorubicin—lung cancer	6.3e-05	0.000456	CcSEcCtD
Mifepristone—Hypersensitivity—Methotrexate—lung cancer	6.27e-05	0.000454	CcSEcCtD
Mifepristone—ABCB1—respiratory system—lung cancer	6.13e-05	0.0212	CbGeAlD
Mifepristone—CYP3A5—lung—lung cancer	6.13e-05	0.0212	CbGeAlD
Mifepristone—Asthenia—Methotrexate—lung cancer	6.1e-05	0.000442	CcSEcCtD
Mifepristone—NR3C1—lung—lung cancer	6.08e-05	0.021	CbGeAlD
Mifepristone—Feeling abnormal—Doxorubicin—lung cancer	6.07e-05	0.00044	CcSEcCtD
Mifepristone—Gastrointestinal pain—Doxorubicin—lung cancer	6.02e-05	0.000437	CcSEcCtD
Mifepristone—Pruritus—Methotrexate—lung cancer	6.02e-05	0.000436	CcSEcCtD
Mifepristone—Urticaria—Doxorubicin—lung cancer	5.85e-05	0.000424	CcSEcCtD
Mifepristone—Abdominal pain—Doxorubicin—lung cancer	5.82e-05	0.000422	CcSEcCtD
Mifepristone—Body temperature increased—Doxorubicin—lung cancer	5.82e-05	0.000422	CcSEcCtD
Mifepristone—Diarrhoea—Methotrexate—lung cancer	5.82e-05	0.000422	CcSEcCtD
Mifepristone—AR—lymph node—lung cancer	5.75e-05	0.0199	CbGeAlD
Mifepristone—Dizziness—Methotrexate—lung cancer	5.62e-05	0.000408	CcSEcCtD
Mifepristone—ABCC1—lymph node—lung cancer	5.46e-05	0.0189	CbGeAlD
Mifepristone—Hypersensitivity—Doxorubicin—lung cancer	5.43e-05	0.000393	CcSEcCtD
Mifepristone—Vomiting—Methotrexate—lung cancer	5.41e-05	0.000392	CcSEcCtD
Mifepristone—Rash—Methotrexate—lung cancer	5.36e-05	0.000389	CcSEcCtD
Mifepristone—Dermatitis—Methotrexate—lung cancer	5.36e-05	0.000388	CcSEcCtD
Mifepristone—Headache—Methotrexate—lung cancer	5.33e-05	0.000386	CcSEcCtD
Mifepristone—Asthenia—Doxorubicin—lung cancer	5.28e-05	0.000383	CcSEcCtD
Mifepristone—Pruritus—Doxorubicin—lung cancer	5.21e-05	0.000378	CcSEcCtD
Mifepristone—ABCB1—epithelium—lung cancer	5.13e-05	0.0177	CbGeAlD
Mifepristone—Nausea—Methotrexate—lung cancer	5.05e-05	0.000366	CcSEcCtD
Mifepristone—Diarrhoea—Doxorubicin—lung cancer	5.04e-05	0.000365	CcSEcCtD
Mifepristone—Dizziness—Doxorubicin—lung cancer	4.87e-05	0.000353	CcSEcCtD
Mifepristone—Vomiting—Doxorubicin—lung cancer	4.68e-05	0.000339	CcSEcCtD
Mifepristone—Rash—Doxorubicin—lung cancer	4.64e-05	0.000337	CcSEcCtD
Mifepristone—Dermatitis—Doxorubicin—lung cancer	4.64e-05	0.000336	CcSEcCtD
Mifepristone—Headache—Doxorubicin—lung cancer	4.61e-05	0.000334	CcSEcCtD
Mifepristone—ABCB1—trachea—lung cancer	4.53e-05	0.0157	CbGeAlD
Mifepristone—Nausea—Doxorubicin—lung cancer	4.37e-05	0.000317	CcSEcCtD
Mifepristone—NR3C1—lymph node—lung cancer	4.16e-05	0.0144	CbGeAlD
Mifepristone—ABCB1—bone marrow—lung cancer	3.6e-05	0.0124	CbGeAlD
Mifepristone—ABCB1—lung—lung cancer	3.26e-05	0.0113	CbGeAlD
Mifepristone—ABCB1—lymph node—lung cancer	2.23e-05	0.0077	CbGeAlD
Mifepristone—ABCB1—Metabolism—UGT1A1—lung cancer	9.88e-06	0.000115	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—POMC—lung cancer	9.88e-06	0.000115	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ABCB1—lung cancer	9.8e-06	0.000114	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—BRAF—lung cancer	9.75e-06	0.000113	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	9.68e-06	0.000112	CbGpPWpGaD
Mifepristone—ABCC1—Disease—APC—lung cancer	9.67e-06	0.000112	CbGpPWpGaD
Mifepristone—ABCC1—Disease—KIT—lung cancer	9.67e-06	0.000112	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL6R—lung cancer	9.64e-06	0.000112	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—TYMS—lung cancer	9.63e-06	0.000112	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CREBBP—lung cancer	9.62e-06	0.000112	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKR1C1—lung cancer	9.59e-06	0.000111	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EGF—lung cancer	9.56e-06	0.000111	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GNG11—lung cancer	9.53e-06	0.000111	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTM1—lung cancer	9.51e-06	0.00011	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CNDP2—lung cancer	9.45e-06	0.00011	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTM2—lung cancer	9.45e-06	0.00011	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	9.36e-06	0.000109	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—UGT1A1—lung cancer	9.31e-06	0.000108	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MTMR3—lung cancer	9.19e-06	0.000107	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAP2K1—lung cancer	9.18e-06	0.000107	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CD—lung cancer	9.12e-06	0.000106	CbGpPWpGaD
Mifepristone—ABCC1—Disease—BRAF—lung cancer	9.09e-06	0.000106	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP2E1—lung cancer	9.08e-06	0.000105	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ALDOA—lung cancer	9.07e-06	0.000105	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MAPK3—lung cancer	9.03e-06	0.000105	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP1A1—lung cancer	9.02e-06	0.000105	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	9.01e-06	0.000105	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IL6R—lung cancer	8.98e-06	0.000104	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GNG11—lung cancer	8.98e-06	0.000104	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NQO1—lung cancer	8.97e-06	0.000104	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CREBBP—lung cancer	8.97e-06	0.000104	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PGAM1—lung cancer	8.95e-06	0.000104	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ERCC2—lung cancer	8.95e-06	0.000104	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—APOA1—lung cancer	8.87e-06	0.000103	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NCOA3—lung cancer	8.81e-06	0.000102	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MYC—lung cancer	8.78e-06	0.000102	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ABCG2—lung cancer	8.57e-06	9.95e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ADCY1—lung cancer	8.57e-06	9.95e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAP2K1—lung cancer	8.56e-06	9.94e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—CREBBP—lung cancer	8.55e-06	9.93e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ALDOA—lung cancer	8.55e-06	9.92e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP2A7—lung cancer	8.54e-06	9.92e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CD—lung cancer	8.5e-06	9.87e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.5e-06	9.86e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ENO2—lung cancer	8.4e-06	9.75e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—HPGDS—lung cancer	8.4e-06	9.75e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SDC4—lung cancer	8.36e-06	9.71e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PPP2R1B—lung cancer	8.35e-06	9.69e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NCOA3—lung cancer	8.3e-06	9.63e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MDM2—lung cancer	8.17e-06	9.49e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTT1—lung cancer	8.15e-06	9.46e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—RAF1—lung cancer	8.14e-06	9.46e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CG—lung cancer	8.1e-06	9.41e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—STK11—lung cancer	8.09e-06	9.39e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ABCG2—lung cancer	8.07e-06	9.37e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ADCY1—lung cancer	8.07e-06	9.37e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ERBB2—lung cancer	8.06e-06	9.36e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP2A6—lung cancer	8.05e-06	9.35e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GCLC—lung cancer	8.05e-06	9.35e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CB—lung cancer	7.95e-06	9.23e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MTOR—lung cancer	7.95e-06	9.23e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ENO2—lung cancer	7.92e-06	9.19e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—HPGDS—lung cancer	7.92e-06	9.19e-05	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	7.91e-06	9.18e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PPP2R1B—lung cancer	7.87e-06	9.13e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—APOA1—lung cancer	7.74e-06	8.99e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—POMC—lung cancer	7.71e-06	8.95e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTT1—lung cancer	7.68e-06	8.91e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CXCL8—lung cancer	7.64e-06	8.87e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ENO1—lung cancer	7.63e-06	8.86e-05	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	7.63e-06	8.86e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MDM2—lung cancer	7.62e-06	8.84e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTA3—lung cancer	7.61e-06	8.84e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—RRM1—lung cancer	7.61e-06	8.84e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—RAF1—lung cancer	7.59e-06	8.81e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GCLC—lung cancer	7.59e-06	8.81e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP2A6—lung cancer	7.59e-06	8.81e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CREBBP—lung cancer	7.51e-06	8.72e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ERBB2—lung cancer	7.51e-06	8.72e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTP1—lung cancer	7.48e-06	8.69e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MTOR—lung cancer	7.41e-06	8.61e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CB—lung cancer	7.41e-06	8.61e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CD4—lung cancer	7.4e-06	8.59e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTGS2—lung cancer	7.34e-06	8.53e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CASP3—lung cancer	7.31e-06	8.49e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL2—lung cancer	7.3e-06	8.48e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CAT—lung cancer	7.28e-06	8.46e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ENO1—lung cancer	7.19e-06	8.35e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—B4GALT5—lung cancer	7.16e-06	8.31e-05	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	7.14e-06	8.29e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CD—lung cancer	7.12e-06	8.27e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCND1—lung cancer	7.12e-06	8.27e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—JUN—lung cancer	7.1e-06	8.25e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ABCB1—lung cancer	7.08e-06	8.23e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CG—lung cancer	7.06e-06	8.2e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ALB—lung cancer	7.03e-06	8.16e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTA4—lung cancer	6.96e-06	8.09e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TYMS—lung cancer	6.96e-06	8.08e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MMP9—lung cancer	6.91e-06	8.02e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN1A—lung cancer	6.89e-06	8e-05	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MAPK3—lung cancer	6.88e-06	7.99e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTM1—lung cancer	6.88e-06	7.99e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTEN—lung cancer	6.87e-06	7.98e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP2E1—lung cancer	6.85e-06	7.95e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTA2—lung cancer	6.79e-06	7.88e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NQO1—lung cancer	6.77e-06	7.86e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—POMC—lung cancer	6.72e-06	7.81e-05	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MYC—lung cancer	6.69e-06	7.77e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EP300—lung cancer	6.55e-06	7.61e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CREBBP—lung cancer	6.55e-06	7.61e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTA1—lung cancer	6.55e-06	7.6e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP1A1—lung cancer	6.52e-06	7.57e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCC3—lung cancer	6.47e-06	7.52e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ERCC2—lung cancer	6.47e-06	7.51e-05	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	6.46e-06	7.5e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP2E1—lung cancer	6.45e-06	7.49e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN1A—lung cancer	6.42e-06	7.45e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTEN—lung cancer	6.4e-06	7.44e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NQO1—lung cancer	6.38e-06	7.41e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SRC—lung cancer	6.37e-06	7.4e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKR1C1—lung cancer	6.27e-06	7.28e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CD—lung cancer	6.21e-06	7.21e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CB—lung cancer	6.21e-06	7.21e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—VEGFA—lung cancer	6.21e-06	7.21e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGS2—lung cancer	6.15e-06	7.14e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—STAT3—lung cancer	6.14e-06	7.13e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ALB—lung cancer	6.13e-06	7.12e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NRAS—lung cancer	6.13e-06	7.12e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EP300—lung cancer	6.11e-06	7.09e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—STK11—lung cancer	6.1e-06	7.09e-05	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—AKT1—lung cancer	6.09e-06	7.07e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—UGT1A1—lung cancer	6.09e-06	7.07e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SRC—lung cancer	5.94e-06	6.9e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAPK3—lung cancer	5.87e-06	6.82e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GNG11—lung cancer	5.87e-06	6.81e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—STK11—lung cancer	5.75e-06	6.68e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—STAT3—lung cancer	5.73e-06	6.65e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NRAS—lung cancer	5.71e-06	6.63e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MYC—lung cancer	5.71e-06	6.63e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTP1—lung cancer	5.65e-06	6.56e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—APOA1—lung cancer	5.59e-06	6.5e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALDOA—lung cancer	5.59e-06	6.49e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EGFR—lung cancer	5.58e-06	6.48e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CAT—lung cancer	5.5e-06	6.38e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAPK3—lung cancer	5.47e-06	6.35e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NCOA3—lung cancer	5.43e-06	6.3e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CB—lung cancer	5.41e-06	6.29e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGS2—lung cancer	5.36e-06	6.23e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTEN—lung cancer	5.36e-06	6.23e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MYC—lung cancer	5.32e-06	6.18e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTP1—lung cancer	5.32e-06	6.18e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ADCY1—lung cancer	5.28e-06	6.13e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCG2—lung cancer	5.28e-06	6.13e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KRAS—lung cancer	5.28e-06	6.13e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TYMS—lung cancer	5.25e-06	6.1e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MAPK3—lung cancer	5.22e-06	6.06e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EGFR—lung cancer	5.21e-06	6.04e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTM1—lung cancer	5.19e-06	6.03e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CAT—lung cancer	5.18e-06	6.01e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HPGDS—lung cancer	5.18e-06	6.01e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ENO2—lung cancer	5.18e-06	6.01e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.14e-06	5.97e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—EP300—lung cancer	5.11e-06	5.94e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CG—lung cancer	5.11e-06	5.93e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MYC—lung cancer	5.08e-06	5.89e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ABCB1—lung cancer	5.04e-06	5.85e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTT1—lung cancer	5.02e-06	5.83e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP2A6—lung cancer	4.96e-06	5.76e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GCLC—lung cancer	4.96e-06	5.76e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TYMS—lung cancer	4.95e-06	5.74e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP1A1—lung cancer	4.92e-06	5.71e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—KRAS—lung cancer	4.92e-06	5.71e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTM1—lung cancer	4.89e-06	5.68e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ERCC2—lung cancer	4.88e-06	5.67e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—POMC—lung cancer	4.86e-06	5.64e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CA—lung cancer	4.85e-06	5.63e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CREBBP—lung cancer	4.73e-06	5.5e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ENO1—lung cancer	4.7e-06	5.46e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—lung cancer	4.69e-06	5.44e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTEN—lung cancer	4.68e-06	5.43e-05	CbGpPWpGaD
Mifepristone—AR—Gene Expression—AKT1—lung cancer	4.64e-06	5.39e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP1A1—lung cancer	4.64e-06	5.38e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ERCC2—lung cancer	4.6e-06	5.34e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CA—lung cancer	4.52e-06	5.25e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CD—lung cancer	4.49e-06	5.21e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HRAS—lung cancer	4.48e-06	5.21e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—EP300—lung cancer	4.46e-06	5.18e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ALB—lung cancer	4.43e-06	5.15e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL6—lung cancer	4.29e-06	4.98e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—APOA1—lung cancer	4.22e-06	4.9e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP2E1—lung cancer	4.22e-06	4.9e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HRAS—lung cancer	4.18e-06	4.85e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NQO1—lung cancer	4.17e-06	4.84e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IL6—lung cancer	4e-06	4.65e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—APOA1—lung cancer	3.98e-06	4.62e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AKT1—lung cancer	3.96e-06	4.6e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CB—lung cancer	3.91e-06	4.54e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGS2—lung cancer	3.88e-06	4.5e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CG—lung cancer	3.85e-06	4.47e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CA—lung cancer	3.78e-06	4.39e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—STK11—lung cancer	3.76e-06	4.37e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AKT1—lung cancer	3.69e-06	4.29e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—POMC—lung cancer	3.67e-06	4.26e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CG—lung cancer	3.63e-06	4.22e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CREBBP—lung cancer	3.57e-06	4.15e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—AKT1—lung cancer	3.52e-06	4.09e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTP1—lung cancer	3.48e-06	4.04e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—POMC—lung cancer	3.46e-06	4.01e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CD—lung cancer	3.39e-06	3.93e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CAT—lung cancer	3.39e-06	3.93e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTEN—lung cancer	3.38e-06	3.93e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CREBBP—lung cancer	3.37e-06	3.91e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ALB—lung cancer	3.34e-06	3.88e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CA—lung cancer	3.3e-06	3.83e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCB1—lung cancer	3.29e-06	3.82e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TYMS—lung cancer	3.23e-06	3.76e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—EP300—lung cancer	3.22e-06	3.74e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTM1—lung cancer	3.2e-06	3.71e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CD—lung cancer	3.19e-06	3.71e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ALB—lung cancer	3.15e-06	3.66e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AKT1—lung cancer	3.09e-06	3.59e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP1A1—lung cancer	3.03e-06	3.52e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ERCC2—lung cancer	3.01e-06	3.49e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CB—lung cancer	2.95e-06	3.43e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGS2—lung cancer	2.93e-06	3.4e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CB—lung cancer	2.78e-06	3.23e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGS2—lung cancer	2.76e-06	3.2e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AKT1—lung cancer	2.7e-06	3.13e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—APOA1—lung cancer	2.6e-06	3.02e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTEN—lung cancer	2.55e-06	2.96e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—EP300—lung cancer	2.43e-06	2.83e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTEN—lung cancer	2.4e-06	2.79e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CA—lung cancer	2.39e-06	2.77e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CG—lung cancer	2.37e-06	2.76e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—EP300—lung cancer	2.29e-06	2.66e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—POMC—lung cancer	2.26e-06	2.62e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CREBBP—lung cancer	2.2e-06	2.56e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CD—lung cancer	2.09e-06	2.42e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALB—lung cancer	2.06e-06	2.39e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AKT1—lung cancer	1.95e-06	2.26e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CB—lung cancer	1.82e-06	2.11e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGS2—lung cancer	1.8e-06	2.09e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CA—lung cancer	1.8e-06	2.09e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CA—lung cancer	1.7e-06	1.97e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTEN—lung cancer	1.57e-06	1.83e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—EP300—lung cancer	1.5e-06	1.74e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AKT1—lung cancer	1.47e-06	1.71e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKT1—lung cancer	1.39e-06	1.61e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CA—lung cancer	1.11e-06	1.29e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKT1—lung cancer	9.06e-07	1.05e-05	CbGpPWpGaD
